Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$0.49 - $0.61 $12,407 - $15,446
25,322 Added 6.19%
434,442 $265,000
Q3 2022

Nov 14, 2022

BUY
$0.0 - $0.93 $0 - $107,531
115,625 Added 39.4%
409,120 $174,000
Q2 2022

Aug 15, 2022

BUY
$0.38 - $0.89 $42,310 - $99,096
111,344 Added 61.13%
293,495 $238,000
Q1 2022

May 16, 2022

SELL
$0.58 - $0.86 $267,033 - $395,945
-460,402 Reduced 71.65%
182,151 $110,000
Q4 2021

Feb 14, 2022

SELL
$0.73 - $1.28 $39,141 - $68,632
-53,619 Reduced 7.7%
642,553 $524,000
Q3 2021

Nov 15, 2021

SELL
$0.77 - $4.91 $65,357 - $416,760
-84,880 Reduced 10.87%
696,172 $552,000
Q2 2021

Aug 11, 2021

SELL
$2.18 - $4.66 $15,229 - $32,554
-6,986 Reduced 0.89%
781,052 $3.61 Million
Q1 2021

May 17, 2021

BUY
$1.3 - $3.24 $660,307 - $1.65 Million
507,929 Added 181.33%
788,038 $2.05 Million
Q4 2020

Feb 16, 2021

BUY
$1.01 - $1.77 $215,889 - $378,341
213,752 Added 322.12%
280,109 $378,000
Q2 2020

Aug 14, 2020

SELL
$0.52 - $0.87 $346,362 - $579,491
-666,082 Reduced 90.94%
66,357 $48,000
Q1 2020

May 15, 2020

BUY
$0.39 - $1.03 $33,809 - $89,290
86,690 Added 13.42%
732,439 $411,000
Q4 2019

Feb 14, 2020

BUY
$0.89 - $1.5 $338,081 - $569,800
379,867 Added 142.87%
645,749 $672,000
Q3 2019

Nov 14, 2019

BUY
$1.04 - $1.51 $163,911 - $237,986
157,607 Added 145.56%
265,882 $311,000
Q2 2019

Aug 16, 2019

BUY
$0.95 - $2.46 $8,785 - $22,750
9,248 Added 9.34%
108,275 $162,000
Q2 2019

Aug 14, 2019

BUY
$0.95 - $2.46 $55,782 - $144,446
58,718 Added 145.67%
99,027 $149,000
Q1 2019

May 15, 2019

BUY
$0.69 - $1.47 $27,813 - $59,254
40,309 New
40,309 $42,000
Q4 2018

Feb 14, 2019

SELL
$0.96 - $2.04 $80,908 - $171,931
-84,280 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$1.54 - $2.38 $50,473 - $78,004
32,775 Added 63.63%
84,280 $181,000
Q2 2018

Aug 14, 2018

BUY
$1.04 - $3.29 $53,565 - $169,451
51,505 New
51,505 $100,000

Others Institutions Holding SESN

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0

About Sesen Bio, Inc.


  • Ticker SESN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 201,702,000
  • Market Cap $127M
  • Description
  • Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment...
More about SESN
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.